The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Molecular Mechanisms of Schizophrenia
Abstract
Schizophrenia is a complex disorder, where family, twin and adoption studies have been demonstrating a high heritability of the disease and that this disease is not simply defined by several major genes but rather evolves from addition or potentiation of a specific cluster of genes, which subsequently determines the genetic vulnerability of an individual. Linkage and association studies suggest that a genetic vulnerablility, is not forcefully leading to the disease since triggering factors and environmental influences, i.e. birth complications, drug abuse, urban background or time of birth have been identified. This has lead to the assumption that schizophrenia is not only a genetically defined static disorder but a dynamic process leading to dysregulation of multiple pathways. There are several different hypothesis based on several facets of the disease, some of them due to the relatively well-known mechanisms of therapeutic agents. The most widely considered neurodevelopmental hypothesis of schizophrenia integrates environmental influences and causative genes. The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning. The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3). Correspondingly, GABA has been proposed to modulate the pathophysiology of the disease which is represented by the involvement of genes like GABRA1, GABRP, GABRA6 and Reelin. Moreover, several genes implicating immune, signaling and networking deficits have been reported to be involved in the disease, i.e. DISC1, RGS4, PRODH, DGCR6, ZDHHC8, DGCR2, Akt, CREB, IL-1B, IL-1RN, IL-10, IL-1B. However, molecular findings suggest that a complex interplay between receptors, kinases, proteins and hormones is involved in schizophrenia. In a unifying hypothesis, different cascades merge into another that ultimately lead to the development of symptoms adherent to schizophrenic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,139
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341750 · Cited by 856
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412499 · Cited by 829
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811
Wolosker, H., Blackshaw, S., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13409 · Cited by 811
Kendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110060007 · Cited by 676
A polygenic theory of schizophrenia.
Gottesman, I. I., & Shields, J. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.1.199 · Cited by 636
The Regulator of G Protein Signaling Family
De Vries, L., Zheng, B., Fischer, T., Elenko, E., & Farquhar, M. G. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.235 · Cited by 592
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder
Segurado, R., Detera-Wadleigh, S. D., Levinson, D. F., Lewis, C. M., Gill, M., Nurnberger, J. I., Craddock, N., DePaulo, J. R., Baron, M., Gershon, E. S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376547 · Cited by 569
Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia
Hahn, C.-G., Wang, H.-Y., Cho, D.-S., Talbot, K., Gur, R. E., Berrettini, W. H., Bakshi, K., Kamins, J., Borgmann-Winter, K. E., Siegel, S. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1418 · Cited by 563
Prenatal Infection as a Risk Factor for Schizophrenia
Brown, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj052 · Cited by 539
A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development
Kamiya, A., Kubo, K.-I., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1328 · Cited by 531
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia
Callicott, J. H., Straub, R. E., Pezawas, L., Egan, M. F., Mattay, V. S., Hariri, A. R., Verchinski, B. A., Meyer-Lindenberg, A., Balkissoon, R., Kolachana, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500515102 · Cited by 516
Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis
Torrey, E. F., Bartko, J. J., Lun, Z.-R., & Yolken, R. H. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl050 · Cited by 503
Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology
Craddock, N. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj033 · Cited by 496
Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703806104 · Cited by 483
Arinami, T. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.577 · Cited by 455
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446
Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., Okawa, M., Yamada, N., Hatten, M. E., Snyder, S. H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136913100 · Cited by 392
Heresco-Levy, U., Javitt, D. C., Ebstein, R., Vass, A., Lichtenberg, P., Bar, G., Catinari, S., & Ermilov, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.037 · Cited by 386
Morris, J. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg162 · Cited by 376
Association and linkage analyses of RGS4 polymorphisms in schizophrenia
Chowdari, K. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1373 · Cited by 368
Akbarian, S., & Huang, H.-S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.001 · Cited by 363
Weickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.544 · Cited by 352
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia
Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N., Ozaki, N., Taguchi, T., Tatsumi, M., Kamijima, K., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh280 · Cited by 349
Cannon, T. D., Hennah, W., van Erp, T. G. M., Thompson, P. M., Lonnqvist, J., Huttunen, M., Gasperoni, T., Tuulio-Henriksson, A., Pirkola, T., Toga, A. W., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1205 · Cited by 337
Cell biology of the hippocampal formation in schizophrenia
Weinberger, D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00331-x · Cited by 321
The molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 321
COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome
Gothelf, D., Eliez, S., Thompson, T., Hinard, C., Penniman, L., Feinstein, C., Kwon, H., Jin, S., Jo, B., Antonarakis, S. E., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1572 · Cited by 319
Impact of complex genetic variation in COMT on human brain function
Meyer-Lindenberg, A., Nichols, T., Callicott, J. H., Ding, J., Kolachana, B., Buckholtz, J., Mattay, V. S., Egan, M., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 319
Diverse Psychotomimetics Act Through a Common Signaling Pathway
Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 314
Schizophrenia: a common disease caused by multiple rare alleles
McClellan, J. M., Susser, E., & King, M.-C. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.025585 · Cited by 296
Meta-analysis shows strong positive association of the neuregulin 1 ( NRG1 ) gene with schizophrenia
Li, D., Collier, D. A., & He, L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl122 · Cited by 295
AKHONDZADEH, S., TABATABAEE, M., AMINI, H., AHMADIABHARI, S., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 289
Spatial working memory as an endophenotype for schizophrenia
Glahn, D. C., Therman, S., Manninen, M., Huttunen, M., Kaprio, J., Lönnqvist, J., & Cannon, T. D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01641-4 · Cited by 283
Schizophrenia: More dopamine, more D 2 receptors
Seeman, P., & Kapur, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7673 · Cited by 279
Lane, H.-Y., Chang, Y.-C., Liu, Y.-C., Chiu, C.-C., & Tsai, G. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1196 · Cited by 271
Novel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 262
Munafò, M. R., Bowes, L., Clark, T. G., & Flint, J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001664 · Cited by 259
Ehrenreich, H., Hinze-Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., Heinz, G., Erdag, S., Jahn, H., Degner, D., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001907 · Cited by 258
Hirvonen, M., Laakso, A., Någren, K., Rinne, J. O., Pohjalainen, T., & Hietala, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001561 · Cited by 248
DeLisi, L. E., Shaw, S. H., Crow, T. J., Shields, G., Smith, A. B., Larach, V. W., Wellman, N., Loftus, J., Nanthakumar, B., Razi, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.803 · Cited by 246
Risk Factors for the Emergence of Psychotic Disorders in Adolescents With 22q11.2 Deletion Syndrome
Gothelf, D., Feinstein, C., Thompson, T., Gu, E., Penniman, L., Van Stone, E., Kwon, H., Eliez, S., & Reiss, A. L. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.663 · Cited by 244
A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms
Hall, J., Whalley, H. C., Job, D. E., Baig, B. J., McIntosh, A. M., Evans, K. L., Thomson, P. A., Porteous, D. J., Cunningham-Owens, D. G., Johnstone, E. C., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1795 · Cited by 241
Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia
Babulas, V., Factor-Litvak, P., Goetz, R., Schaefer, C. A., & Brown, A. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.927 · Cited by 233
Brandon, N. J., Handford, E. J., Schurov, I., Rain, J.-C., Pelling, M., Duran-Jimeniz, B., Camargo, L. M., Oliver, K. R., Beher, D., Shearman, M. S., et al. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.009 · Cited by 224
de Miranda, J., Panizzutti, R., Foltyn, V. N., & Wolosker, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222421299 · Cited by 221
Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity
Foltyn, V. N., Bendikov, I., De Miranda, J., Panizzutti, R., Dumin, E., Shleper, M., Li, P., Toney, M. D., Kartvelishvily, E., & Wolosker, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405726200 · Cited by 219
Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission
MÜller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 214
Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex
Gu, Z., Jiang, Q., Fu, A. K. Y., Ip, N. Y., & Yan, Z. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1086-05.2005 · Cited by 213
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis
Tuominen, H. J., Tiihonen, J., & Wahlbeck, K. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.05.005 · Cited by 209
Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Cao, L. Y., & Shen, Y. C. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00296-1 · Cited by 198
Alimohamad, H., Rajakumar, N., Seah, Y.-H., & Rushlow, W. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.036 · Cited by 187
Korostishevsky, M., Kaganovich, M., Cholostoy, A., Ashkenazi, M., Ratner, Y., Dahary, D., Bernstein, J., Bening-Abu-Shach, U., Ben-Asher, E., Lancet, D., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.006 · Cited by 186
Norton, N., Moskvina, V., Morris, D. W., Bray, N. J., Zammit, S., Williams, N. M., Williams, H. J., Preece, A. C., Dwyer, S., Wilkinson, J. C., et al. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30236 · Cited by 185
Environmental risk factors for psychosis
Dean, K., & Murray, R. M. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/kdean · Cited by 183
Is COMT a Susceptibility Gene for Schizophrenia?
Williams, H. J., Owen, M. J., & O'Donovan, M. C. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm019 · Cited by 177
Association of dopamine D2 receptor molecular variant with schizophrenia
Arinami, T., Hamaguchi, H., Itokawa, M., Enguchi, H., Tagaya, H., Yano, S., Toru, M., & Shimizu, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91581-4 · Cited by 173
Gallinat, J., Bajbouj, M., Sander, T., Schlattmann, P., Xu, K., Ferro, E. F., Goldman, D., & Winterer, G. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01973-x · Cited by 173
Self-citationThe Genetics and Biology of Disc1—An Emerging Role in Psychosis and Cognition
Porteous, D. J., Thomson, P., Brandon, N. J., & Millar, J. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.008 · Cited by 172
Gama, C. S., Andreazza, A. C., Kunz, M., Berk, M., Belmonte-de-Abreu, P. S., & Kapczinski, F. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.001 · Cited by 172
Schwab, S. G., Hoefgen, B., Hanses, C., Hassenbach, M. B., Albus, M., Lerer, B., Trixler, M., Maier, W., & Wildenauer, D. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.005 · Cited by 169
James, R., Adams, R. R., CHRISTIE, S., Buchanan, S. R., Porteous, D. J., & Millar, J. K. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.013 · Cited by 169
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs
Lipska, B. K., Peters, T., Hyde, T. M., Halim, N., Horowitz, C., Mitkus, S., Weickert, C. S., Matsumoto, M., Sawa, A., Straub, R. E., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl040 · Cited by 168
Boucher, A. A., Arnold, J. C., Duffy, L., Schofield, P. R., Micheau, J., & Karl, T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0721-3 · Cited by 168
Evidence for Decreased DARPP-32 in the Prefrontal Cortex of Patients With Schizophrenia
Albert, K. A., Hemmings, H. C., Adamo, A. I. B., Potkin, S. G., Akbarian, S., Sandman, C. A., Cotman, C. W., Bunney, W. E., & Greengard, P. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.8.705 · Cited by 168
DARPP-32 mediates the actions of multiple drugs of abuse
Svenningsson, P., Nairn, A. C., & Greengard, P. (2005) · The AAPS Journal · doi:10.1208/aapsj070235 · Cited by 167
Nicodemus, K. K., Kolachana, B. S., Vakkalanka, R., Straub, R. E., Giegling, I., Egan, M. F., Rujescu, D., & Weinberger, D. R. (2006) · Human Genetics · doi:10.1007/s00439-006-0257-3 · Cited by 167
Kundakovic, M., Chen, Y., Costa, E., & Grayson, D. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030635 · Cited by 167
Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia
Schmidt‐Kastner, R., van Os, J., Steinbusch, H. W. M., & Schmitz, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.022 · Cited by 166
Austin, C. P., Ky, B., Ma, L., Morris, J. A., & Shughrue, P. J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.010 · Cited by 165
Schurov, I. L., Handford, E. J., Brandon, N. J., & Whiting, P. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001574 · Cited by 163
Association of the DTNBP1 Locus with Schizophrenia in a U.S. Population
Funke, B., Finn, C. T., Plocik, A. M., Lake, S., DeRosse, P., Kane, J. M., Kucherlapati, R., & Malhotra, A. K. (2004) · The American Journal of Human Genetics · doi:10.1086/425279 · Cited by 161
Yamada, K., Ohnishi, T., Hashimoto, K., Ohba, H., Iwayama‐Shigeno, Y., Toyoshima, M., Okuno, A., Takao, H., Toyota, T., Minabe, Y., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.018 · Cited by 160
Recent Advances in the Neurobiology of Schizophrenia
Miyamoto, S. (2003) · Molecular Interventions · doi:10.1124/mi.3.1.27 · Cited by 156
Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin
Talbot, K., Cho, D.-S., Ong, W., Benson, M. A., Han, L.-Y., Kazi, H., Kamins, J., Hahn, C.-G., Blake, D. J., & Arnold, S. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl246 · Cited by 156
Kirov, G., Ivanov, D. K., Williams, N. M., Preece, A. C., Nikolov, I., Milev, R., Koleva, S., Dimitrova, A., Toncheva, D. I., O’Donovan, M. C., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.025 · Cited by 156
Schizophrenia as a developmental disorder of the cerebral cortex
Raedler, T. J., Knable, M. B., & Weinberger, D. R. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80019-6 · Cited by 155
Phosphoinositide 3-kinases as a common platform for multi-hormone signaling
Hirsch, E., Costa, C., & Ciraolo, E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0097 · Cited by 151
Association of AKT1 with schizophrenia confirmed in a Japanese population
Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Inada, T., & Ozaki, N. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.023 · Cited by 150
The molecular genetics of the 22q11-associated schizophrenia
Karayiorgou, M., & Gogos, J. A. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.029 · Cited by 150
Support for RGS4 as a susceptibility gene for schizophrenia
Williams, N. M., Preece, A. C., Spurlock, G., Norton, N., Williams, H. J., McCreadie, R. G., Buckland, P. R., Sharkey, V., Chowdari, K. V., Zammit, S., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.002 · Cited by 145
The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia
Goldberg, T. E., Straub, R. E., Callicott, J. H., Hariri, A. R., Mattay, V. S., Bigelow, L. B., Coppola, R., Egan, M. F., & Weinberger, D. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301049 · Cited by 142
Suarez, B. K., Duan, J., Sanders, A. R., Hinrichs, A. L., Jin, C. H., Hou, C., Buccola, N. G., Hale, N., Weilbaecher, A., Nertney, D. A., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/500272 · Cited by 139
Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia
Petryshen, T. L., Middleton, F. A., Tahl, A. R., Rockwell, G. N., Purcell, S., Aldinger, K. A., Kirby, A. W., Morley, C. P., McGann, L., Gentile, K. L., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001739 · Cited by 136
Multi-Tasking RGS Proteins in the Heart
Riddle, E. L., Schwartzman, R. A., Bond, M., & Insel, P. A. (2005) · Circulation Research · doi:10.1161/01.res.0000158287.49872.4e · Cited by 135
Kanazawa, T., Glatt, S. J., Kia-Keating, B. M., Yoneda, H., & Tsuang, M. T. (2007) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32801da2e2 · Cited by 134
Schulze, T. G., Ohlraun, S., Czerski, P. M., Schumacher, J. H., Kassem, L., Deschner, M., Groß, M., Tullius, M., Heidmann, V., Kovalenko, S., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2101 · Cited by 133
The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia
Dubertret, C., Gouya, L., Hanoun, N., Deybach, J., Adès, J., Hamon, M., & Gorwood, P. A. P. M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00220-2 · Cited by 132
Reynolds, G. P., Yao, Z., Zhang, X., Sun, J., & Zhang, Z. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.07.001 · Cited by 132
Fujii, Y., Shibata, H., Kikuta, R., Makino, C., Tani, A., Hirata, N., Shibata, A., Ninomiya, H., Tashiro, N., & Fukumaki, Y. (2003) · Psychiatric Genetics · doi:10.1097/01.ypg.0000056682.82896.b0 · Cited by 128
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia
Glatt, S. J., Faraone, S. V., & Tsuang, M. T. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001321 · Cited by 125
Low GSK-3 activity in frontal cortex of schizophrenic patients
Kozlovsky, N., Belmaker, R. H., & Agam, G. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00174-2 · Cited by 122
Heresco‐Levy, U., & Javitt, D. C. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00129-4 · Cited by 121
A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia
Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.025 · Cited by 119
The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia
Kalkman, H. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.014 · Cited by 116
DISC1 localizes to the centrosome by binding to kendrin
Miyoshi, K., Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., Katayama, T., Tohyama, M., & Ogawa, N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.163 · Cited by 114
P300 and Genetic Risk for Schizophrenia
Winterer, G., Egan, M. F., Raedler, T. J., Sanchez, C. E., Jones, D. W., Coppola, R., & Weinberger, D. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1158 · Cited by 114
Walss‐Bass, C., Liu, W., Lew, D. F., Villegas, R., Montero, P., Dassori, A. M., Leach, R. J., Almasy, L. A., Escamilla, M., & Raventós, H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.017 · Cited by 110
DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex
Kirkpatrick, B., Xu, L., Cascella, N., Ozeki, Y., Sawa, A., & Roberts, R. C. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.21007 · Cited by 104
Florian, M., Lu, Y., Angle, M. R., & Magder, S. A. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.016 · Cited by 102
DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness
Millar, J. K., James, R., Brandon, N. J., & Thomson, P. A. (2004) · Annals of Medicine · doi:10.1080/07853890410033603 · Cited by 101
The genetics of schizophrenia: glutamate not dopamine?
Collier, D. A., & Li, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.105 · Cited by 99
Talkowski, M. E., Seltman, H. J., Bassett, A. S., Brzustowicz, L. M., Chen, X., Chowdari, K. V., Collier, D. A., Cordeiro, Q., Corvin, A. P., Deshpande, S. N., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.015 · Cited by 97
Schwarz, M., Riedel, M. J., Ackenheil, M., & Müller, N. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00206-1 · Cited by 96
Wake, K., Yamazaki, H., Hanzawa, S., Konno, R., Sakio, H., Niwa, A., & Hori, Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01658-x · Cited by 95
Lawford, B. R., Young, R. M., Swagell, C. D., Barnes, M., Burton, S. C., Ward, W. K., Heslop, K., Shadforth, S., van Daal, A., & Morris, C. P. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.020 · Cited by 95
COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance
Burdick, K. E., Funke, B., Goldberg, J. F., Bates, J. A., Jaeger, J., Kucherlapati, R., & Malhotra, A. K. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00384.x · Cited by 95
Gross and Histological Criteria for Developmental Disorders in Brains of Schizophrenics
Jakob, H., & Beckmann, H. (1989) · Journal of the Royal Society of Medicine · doi:10.1177/014107688908200808 · Cited by 95
Arinami, T., Ohtsuki, T., Ishiguro, H., Ujike, H., Tanaka, Y., Morita, Y., Mineta, M., Takeichi, M., Yamada, S., Imamura, A., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498122 · Cited by 93
Sei, Y., Ren‐Patterson, R. F., Li, Z., Tunbridge, E. M., Egan, M. F., Kolachana, B. S., & Weinberger, D. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001994 · Cited by 90
Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy
Fanous, A. H., Neale, M. C., Gardner, C. O., Webb, B. T., Straub, R. E., O’Neill, F. A., Walsh, D., Riley, B. P., & Kendler, K. S. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001996 · Cited by 89
Hennah, W., Tomppo, L., Hiekkalinna, T., Palo, O. M., Kilpinen, H., Ekelund, J., Tuulio‐Henriksson, A., Silander, K., Partonen, T., Paunio, T., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl462 · Cited by 88
Martí, S. B., Cichon, S., Propping, P., & Nöthen, M. M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1624 · Cited by 87
Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia
Sanders, A. R., Rusu, I., Duan, J., Molen, J. E. V., Hou, C., Schwab, S. G., Wildenauer, D. B., Martinez, M. M., & Gejman, P. V. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001586 · Cited by 86
Chen, Q., He, G., Chen, Q., Wu, S., Xu, Y., Feng, G., Li, Y., Wang, L., & He, L. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.07.002 · Cited by 85
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia
Schwarz, M., Krönig, H., Riedel, M. J., Dehning, S., Douhet, A., Spellmann, I., Ackenheil, M., Möller, H., & Müller, N. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0603-9 · Cited by 83
Association of AKT1 haplotype with the risk of schizophrenia in Iranian population
Bajestan, S. N., Sabouri, A. H., Nakamura, M., Takashima, H., Keikhaee, M. R., Behdani, F., Bordbar, M. R. F., Sargolzaee, M. R., Bajestan, M. N., Sabouri, Z., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30291 · Cited by 83
Bishop, J. R., Ellingrod, V. L., Moline, J., & Miller, D. D. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.001 · Cited by 82
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia
Boks, M. P., Rietkerk, T., van de Beek, M. H., Sommer, I. E., de Koning, T. J., & Kahn, R. S. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.12.003 · Cited by 82
Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia
Jönsson, E. G., Nöthen, M. M., Neidt, H., Forslund, K., Rylander, G., Mattila‐Evenden, M., Åsberg, M., Propping, P., & Sedvall, G. C. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00033-x · Cited by 82
Li, D., & He, L. (2007) · Genetics in Medicine · doi:10.1097/01.gim.0000250507.96760.4b · Cited by 79
Dopamine D3 Receptor Ser9Gly Polymorphism and Risperidone Response
Lane, H., Hsu, S.-K., Liu, Y., Chang, Y., Huang, C.-H., & Chang, W. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150226.84371.76 · Cited by 76
New genes associated with schizophrenia in neurite formation: a review of cell culture experiments
Bellon, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001985 · Cited by 75
Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia
DeRosse, P., Hodgkinson, C. A., Lencz, T., Burdick, K. E., Kane, J. M., Goldman, D. A., & Malhotra, A. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.023 · Cited by 75
Hayashi, M. A. F., Portaro, F. C. V., Bastos, M. F., Guerreiro, J. R., Oliveira, V., Gorrão, S. S., Tambourgi, D. V., Sant’Anna, O. A., Whiting, P. J., Camargo, L. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500330102 · Cited by 75
Ehlis, A., Reif, A., Herrmann, M. J., Lesch, K., & Fallgatter, A. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301151 · Cited by 74
Stöber, G., Jatzke, S., Heils, A., Jungkunz, G., Knapp, M., Mößner, R., Riederer, P. F., & Lesch, K. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050041 · Cited by 73
3-Methoxy-4 5-methylenedioxy Amphetamine, a New Psychotomimetic Agent
Shulgin, A. T. (1964) · Nature · doi:10.1038/2011120a0 · Cited by 73
Zhao, X., Li, H., Shi, Y., Tang, R., Chen, W., Liu, J., Feng, G., Shi, J., Yan, L., Liu, H., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.023 · Cited by 70
Shirts, B. H., Wood, J. A., Yolken, R. H., & Nimgaonkar, V. L. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.037 · Cited by 67
Breen, G. D., Brown, J. L., Maude, S., Fox, H. C., Collier, D. A., Li, T., Arranz, M. J., Shaw, D., & Clair, D. S. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4<407::aid-ajmg19>3.0.co;2-3 · Cited by 67
Roberts, R. C. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl063 · Cited by 66
Avguštin, B., Wraber, B., & Tavčar, R. (2005) · PubMed · Cited by 65
Talkowski, M. E., Mansour, H., Chowdari, K. V., Wood, J. A., Butler, A., Varma, P. G., Prasad, S., Semwal, P., Triptish Bhatia, A., Deshpande, S. N., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.012 · Cited by 64
Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele
Schürhoff, F., Szöke, A., Chevalier, F., Roy, I., Méary, A., Bellivier, F., Giros, B., & Leboyer, M. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30395 · Cited by 64
Deng, X., Shibata, H., Takeuchi, N., Rachi, S., Sakai, M., Ninomiya, H., Iwata, N., Ozaki, N., & Fukumaki, Y. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30351 · Cited by 62
Brain‐Derived Neurotrophic Factor in Schizophrenia and Its Relation With Dopamine
Guillin, O., Demily, C., & Thibaut, F. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78012-6 · Cited by 61
Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis
Zintzaras, E. (2007) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32801119da · Cited by 61
The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland
Turunen, J. A., Peltonen, J. O., Pietiläinen, O. P. H., Hennah, W., Loukola, A., Paunio, T., Silander, K., Ekelund, J., Varilo, T., Partonen, T., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.028 · Cited by 60
Association analysis of AKT1 and schizophrenia in a UK case control sample
Norton, N., Williams, H. J., Dwyer, S., Carroll, L. S., Peirce, T., Moskvina, V., Segurado, R., Nikolov, I., Williams, N. M., Ikeda, M., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.02.006 · Cited by 60
Cordeiro, Q., Talkowski, M. E., Chowdari, K. V., Wood, J. A., Nimgaonkar, V. L., & Vallada, H. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00096.x · Cited by 58
Chronic amphetamine treatment reduces NGF and BDNF in the rat brain
Angelucci, F., Gruber, S. H. M., Khoury, A. E., Tonali, P. A., & Mathé, A. A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.002 · Cited by 57
Lundorf, M. D., Buttenschøn, H. N., Foldager, L., Blackwood, D. H. R., Muir, W. J., Murray, V., Pelosi, A. J., Kruse, T. A., Ewald, H., & Mors, O. N. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30137 · Cited by 56
Gourion, D., Goldberger, C., Leroy, S., Bourdel, M., Olié, J., & Krebs, M. (2005) · Neuroreport · doi:10.1097/01.wnr.0000175245.58708.6b · Cited by 56
No evidence for association between polymorphisms in GRM3and schizophrenia
Norton, N., Williams, H. J., Dwyer, S., Ivanov, D. K., Preece, A. C., Gerrish, A., Williams, N. M., Yerassimou, P., Zammit, S., O’Donovan, M. C., et al. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-23 · Cited by 56
Disrupted‐in‐Schizophrenia‐1 (DISC1): A Key Susceptibility Factor for Major Mental Illnesses
Sawamura, N., & Sawa, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.018 · Cited by 54
Ohtsuki, T., Inada, T., & Arinami, T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001559 · Cited by 52
Magri, C., Gardella, R., Barlati, S., Podavini, D., Iatropoulos, P., Bonomi, S., Valsecchi, P., Sacchetti, E., & Barlati, S. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30294 · Cited by 52
Staddon, S. L., Arranz, M. J., Mancama, D. T., Perez-Nievas, F., Arrizabalaga, I., Anney, R., Buckland, P. R., Elkin, A., Osborne, S., Munro, J., et al. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.06.011 · Cited by 52
Papiol, S., Molina, V., Desco, M., Rosa, A., Reig, S., Gispert, J. D., Sanz, J., Palomo, T., & Fañanás, L. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.035 · Cited by 50
Deng, X., Shibata, H., Ninomiya, H., Tashiro, N., Iwata, N., Ozaki, N., & Fukumaki, Y. (2004) · BMC Psychiatry · doi:10.1186/1471-244x-4-21 · Cited by 49
Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians
Sobell, J. L., Richard, C., Wirshing, D. A., & Heston, L. L. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30221 · Cited by 49
Marenco, S., Steele, S. U., Egan, M. F., Goldberg, T. E., Straub, R. E., Sharrief, A. Z., & Weinberger, D. R. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.740 · Cited by 48
Chowdari, K. V., Bamne, M. N., Wood, J. A., Talkowski, M. E., Mirnics, K., Levitt, P. R., Lewis, D. A., & Nimgaonkar, V. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm042 · Cited by 48
Kohn, Y., Danilovich, E., Filon, D., Oppenheim, A., Karni, O., Kanyas, K., Turetsky, N., Korner, M., & Lerer, B. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30044 · Cited by 48
Shifman, S., Levit, A., Chen, M., Chen, C., Bronstein, M., Weizman, A., Yakir, B., Navon, R., & Darvasi, A. (2006) · Human Genetics · doi:10.1007/s00439-006-0195-0 · Cited by 47
No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families
Mullé, J. G., Chowdari, K. V., Nimgaonkar, V. L., & Chakravarti, A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001619 · Cited by 46
Dubertret, C., Gorwood, P. A. P. M., Gouya, L., Deybach, J., & Adès, J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00085-2 · Cited by 43
C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients
Hoenicka, J., Aragüés, M., Rodríguez–Jiménez, R., Ponce, G., Martínez, I., Rubio, G., Jiménez‐Arriero, M. Á., & Palomo, T. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00874.x · Cited by 42
Dopamine D2 receptor promoter polymorphism: no association with schizophrenia
Tallerico, T., Ulpian, C., & Liu, I. S. C. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(98)00125-5 · Cited by 41
Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia
Zhang, F., Clair, D. S., Liu, X., Sun, X., Sham, P. C., Crombie, C., Ma, X., Wang, Q., Meng, H., Deng, W., et al. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00167.x · Cited by 41
Roberts, R. C., Roche, J. K., & Conley, R. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.015 · Cited by 41
Relationship between estrogen and schizophrenia
Mortimer, A. M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.45 · Cited by 41
The neuronal pathology of schizophrenia: molecules and mechanisms
Reynolds, G. P., & Harte, M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350433 · Cited by 40
Levant, B., Ling, Z. D., & Carvey, P. M. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00006 · Cited by 39
Puri, V., McQuillin, A., Choudhury, K., Datta, S., Pimm, J., Thirumalai, S., Krasucki, R., Lawrence, J., Quested, D. J., Bass, N. J., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.014 · Cited by 39
Gallinat, J., Götz, T., Kalus, P., Bajbouj, M., Sander, T., & Winterer, G. (2007) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2007.19.1.59 · Cited by 39
Self-citationTochigi, M., Suga, M., Ohashi, J., Otowa, T., Yamasue, H., Kasai, K., Kato, T., Okazaki, Y., Kato, N., & Sasaki, T. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.008 · Cited by 36
Rudolf, S., Peters, M., Rothermundt, M., Arolt, V., & Kirchner, H. (2002) · Neuropsychobiology · doi:10.1159/000067807 · Cited by 34
Novel variants in the promoter region of the CREB gene in schizophrenic patients
Kawanishi, Y., Harada, S., Tachikawa, H., et al. (1999) · Journal of Human Genetics · doi:10.1007/s100380050196 · Cited by 33
Scassellati, C., Bonvicini, C., Pérez, J., Bocchio‐Chiavetto, L., Tura, G. B., Rossi, G., Racagni, G., & Gennarelli, M. (2004) · Neuropsychobiology · doi:10.1159/000077936 · Cited by 31
Falkai, P., & Maier, W. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2197-5 · Cited by 28
Potential genetic variants in schizophrenia: A Bayesian analysis
Hall, H., Lawyer, G., Sillén, A., Jönsson, E. G., Agartz, I., Terenius, L. Y., & Arnborg, S. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600892004 · Cited by 28
Mata, I. F., Crespo‐Facorro, B., Pérez‐Iglesias, R., Carrasco-Marı́n, E., Arranz, M. J., Pelayo‐Terán, J. M., Leyva‐Cobián, F., & Vázquez‐Barquero, J. L. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30405 · Cited by 22
Meng, J., Shi, Y., Zhao, X., Zhou, J. P., Zheng, Y., Tang, R., Ma, G., Zhu, X., He, Z., Wang, Z., et al. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.01.005 · Cited by 16
Yoshikawa, M., Andoh, H., Ito, K., Suzuki, T., Kawaguchi, M., Kobayashi, H., Oka, T., & Hashimoto, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.001 · Cited by 16
Le récepteur dopaminergique D3: nouvelle cible pour un traitement amélioré de la schizophrénie
Millan, M. J. (2005) · médecine/sciences · doi:10.1051/medsci/2005214434 · Cited by 9
Cited by
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390
Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology
TANDON, R., KESHAVAN, M., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.011 · Cited by 720
The dual role of the extracellular matrix in synaptic plasticity and homeostasis
Dityatev, A., Schachner, M., & Sonderegger, P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2898 · Cited by 559
Psychiatric genetics: progress amid controversy
Burmeister, M., McInnis, M. G., & Zöllner, S. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2381 · Cited by 525
Hematopoietic origin of pathological grooming in Hoxb8 mutant mice
Chen, S.-K., Tvrdik, P., Peden, E., Cho, S., Wu, S., Spangrude, G., & Capecchi, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.03.055 · Cited by 450
Metadata
- Authors
- Lang, U. E., Puls, I., Müller, D. J., Strutz-Seebohm, N., & Gallinat, J.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 20
- Issue
- 6
- Pages
- 687-702
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2063619823
- Cited by
- 281
- References
- 189
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.